Orchard Park, NY, United States of America

David Douglas Manning

USPTO Granted Patents = 6 

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 13(Granted Patents)


Location History:

  • Madison, WI (US) (1996)
  • Orland Park, IL (US) (2013)
  • Orchard Park, NY (US) (2022 - 2024)

Company Filing History:


Years Active: 1996-2024

Loading Chart...
6 patents (USPTO):Explore Patents

Title: David Douglas Manning: Innovator in Indole Compounds

Introduction

David Douglas Manning is a notable inventor based in Orchard Park, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly through his work on indole compounds. With a total of six patents to his name, Manning has established himself as a key figure in the innovation landscape.

Latest Patents

Manning's latest patents focus on indole compounds and their applications. The disclosures relate to pharmaceutical compositions that utilize these compounds to stimulate the immune system in patients and to treat cancer. His work in this area highlights the potential of indole compounds in advancing medical treatments.

Career Highlights

Throughout his career, Manning has worked with various companies, including Ariagen, Inc. His experience in the pharmaceutical industry has allowed him to develop innovative solutions that address critical health issues. His dedication to research and development has led to the successful patenting of his inventions.

Collaborations

Manning has collaborated with notable individuals in his field, including Graham Johnson and Peter Colabuono. These partnerships have contributed to the advancement of his research and the successful implementation of his patented technologies.

Conclusion

David Douglas Manning's contributions to the field of pharmaceuticals, particularly through his work on indole compounds, demonstrate his commitment to innovation and improving patient care. His patents reflect a significant advancement in medical science, showcasing the importance of research and collaboration in the development of new treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…